Intervention News

In adults with atrial fibrillation who developed ischemic stroke, those treated with left atrial appendage closure had better outcomes than those receiving direct oral anticoagulant prophylaxis, data from a registry analysis show.

As baby boomers age into their 70s and 80s, it is estimated that more than $84 trillion will pass down through inheritances to millennial and Gen X heirs before 2045.

Influenza vaccination was linked to significant decreased risks for major cardiovascular events and death, according to a study published in Scientific Reports.

Healio | Cardiology Today compiled a list of the top news from the 2023 American Heart Association Scientific Sessions.

PHILADELPHIA — In patients with CAD and ischemic left ventricular dysfunction, PCI did not add significantly more quality-adjusted life-years and cost significantly more compared with optimal medical therapy alone, a speaker reported.

PHILADELPHIA — An artificial intelligence-enabled ECG was associated with shorter time from ECG to catheterization laboratory entry in patients with suspected STEMI, according the results of the ARISE study.

The FDA approved a second renal denervation device to treat adults with uncontrolled hypertension despite an advisory panel’s vote regarding that system’s risks and benefits, Medtronic announced.

SAN FRANCISCO — A large, real-world database analysis showed treatment rates for severe symptomatic aortic stenosis are low years after diagnosis, with mortality risk rising with aortic stenosis severity, researchers reported at TCT 2023.

PHILADELPHIA — In this video exclusive, Deepak L. Bhatt, MD, MPH, provides his perspective on research presented at the American Heart Association Scientific Sessions.

Among the many changes brought by the COVID-19 pandemic was an abrupt switch from in-person to virtual cardiac rehabilitation, a shift that allowed easier access to a service that patients typically struggled to attend, seemingly overnight.